AtriCure Gross Margin 2012-2025 | ATRC
Current and historical gross margin for AtriCure (ATRC) over the last 10 years. The current gross profit margin for AtriCure as of September 30, 2025 is %.
| AtriCure Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.52B | $0.39B | 74.90% |
| 2025-06-30 | $0.50B | $0.37B | 74.80% |
| 2025-03-31 | $0.48B | $0.36B | 75.00% |
| 2024-12-31 | $0.47B | $0.35B | 74.84% |
| 2024-09-30 | $0.45B | $0.34B | 74.78% |
| 2024-06-30 | $0.43B | $0.32B | 74.88% |
| 2024-03-31 | $0.42B | $0.31B | 75.18% |
| 2023-12-31 | $0.40B | $0.30B | 75.44% |
| 2023-09-30 | $0.38B | $0.29B | 75.26% |
| 2023-06-30 | $0.37B | $0.27B | 75.07% |
| 2023-03-31 | $0.35B | $0.26B | 74.79% |
| 2022-12-31 | $0.33B | $0.25B | 74.62% |
| 2022-09-30 | $0.32B | $0.24B | 75.00% |
| 2022-06-30 | $0.30B | $0.23B | 74.92% |
| 2022-03-31 | $0.29B | $0.22B | 75.09% |
| 2021-12-31 | $0.27B | $0.21B | 75.46% |
| 2021-09-30 | $0.26B | $0.19B | 74.81% |
| 2021-06-30 | $0.24B | $0.18B | 74.49% |
| 2021-03-31 | $0.21B | $0.16B | 72.77% |
| 2020-12-31 | $0.21B | $0.15B | 71.98% |
| 2020-09-30 | $0.21B | $0.15B | 72.38% |
| 2020-06-30 | $0.21B | $0.15B | 72.64% |
| 2020-03-31 | $0.23B | $0.17B | 73.91% |
| 2019-12-31 | $0.23B | $0.17B | 74.03% |
| 2019-09-30 | $0.22B | $0.17B | 73.99% |
| 2019-06-30 | $0.22B | $0.16B | 73.61% |
| 2019-03-31 | $0.21B | $0.15B | 73.21% |
| 2018-12-31 | $0.20B | $0.15B | 73.27% |
| 2018-09-30 | $0.20B | $0.14B | 72.82% |
| 2018-06-30 | $0.19B | $0.14B | 73.26% |
| 2018-03-31 | $0.18B | $0.13B | 73.33% |
| 2017-12-31 | $0.17B | $0.13B | 72.99% |
| 2017-09-30 | $0.17B | $0.12B | 72.78% |
| 2017-06-30 | $0.17B | $0.12B | 72.12% |
| 2017-03-31 | $0.16B | $0.12B | 71.88% |
| 2016-12-31 | $0.16B | $0.11B | 71.61% |
| 2016-09-30 | $0.15B | $0.11B | 72.00% |
| 2016-06-30 | $0.14B | $0.10B | 72.03% |
| 2016-03-31 | $0.14B | $0.10B | 71.32% |
| 2015-12-31 | $0.13B | $0.09B | 71.54% |
| 2015-09-30 | $0.12B | $0.09B | 70.73% |
| 2015-06-30 | $0.12B | $0.08B | 70.59% |
| 2015-03-31 | $0.11B | $0.08B | 70.80% |
| 2014-12-31 | $0.11B | $0.08B | 70.37% |
| 2014-09-30 | $0.10B | $0.07B | 71.29% |
| 2014-06-30 | $0.09B | $0.07B | 72.34% |
| 2014-03-31 | $0.09B | $0.06B | 73.56% |
| 2013-12-31 | $0.08B | $0.06B | 74.07% |
| 2013-09-30 | $0.08B | $0.06B | 74.03% |
| 2013-06-30 | $0.07B | $0.05B | 73.97% |
| 2013-03-31 | $0.07B | $0.05B | 73.24% |
| 2012-12-31 | $0.07B | $0.05B | 73.91% |
| 2012-09-30 | $0.07B | $0.05B | 73.53% |
| 2012-06-30 | $0.07B | $0.05B | 73.13% |
| 2012-03-31 | $0.07B | $0.05B | 72.73% |
| 2011-12-31 | $0.07B | $0.05B | 72.31% |
| 2011-09-30 | $0.06B | $0.05B | 73.44% |
| 2011-06-30 | $0.06B | $0.05B | 74.60% |
| 2011-03-31 | $0.06B | $0.05B | 76.67% |
| 2010-12-31 | $0.06B | $0.05B | 77.59% |
| 2010-09-30 | $0.06B | $0.04B | 76.79% |
| 2010-06-30 | $0.06B | $0.04B | 76.36% |
| 2010-03-31 | $0.06B | $0.04B | 76.36% |
| 2009-12-31 | $0.06B | $0.04B | 76.36% |
| 2009-09-30 | $0.05B | $0.04B | 77.36% |
| 2009-06-30 | $0.06B | $0.04B | 76.36% |
| 2009-03-31 | $0.06B | $0.04B | 75.00% |
| 2008-12-31 | $0.06B | $0.04B | 73.21% |
| 2008-09-30 | $0.06B | $0.04B | 75.44% |
| 2008-06-30 | $0.05B | $0.04B | 75.93% |
| 2008-03-31 | $0.05B | $0.04B | 78.43% |
| 2007-12-31 | $0.05B | $0.04B | 81.25% |
| 2007-09-30 | $0.05B | $0.04B | 78.26% |
| 2007-06-30 | $0.04B | $0.03B | 79.07% |
| 2007-03-31 | $0.04B | $0.03B | 78.05% |
| 2006-12-31 | $0.04B | $0.03B | 76.92% |
| 2006-09-30 | $0.04B | $0.03B | 75.68% |
| 2006-06-30 | $0.04B | $0.03B | 74.29% |
| 2006-03-31 | $0.03B | $0.02B | 72.73% |
| 2005-12-31 | $0.03B | $0.02B | 74.19% |
| 2005-09-30 | $0.03B | $0.02B | 76.92% |
| 2005-06-30 | $0.02B | $0.02B | 79.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.871B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.733B | 24.98 |
| EssilorLuxottica (ESLOY) | France | $149.439B | 0.00 |
| Boston Scientific (BSX) | United States | $141.899B | 32.45 |
| Stryker (SYK) | United States | $138.196B | 27.44 |
| Medtronic (MDT) | Ireland | $124.291B | 17.22 |
| Medline (MDLN) | United States | $56.122B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Agilent Technologies (A) | United States | $41.955B | 26.52 |
| GE HealthCare Technologies (GEHC) | United States | $39.585B | 18.93 |
| ResMed (RMD) | United States | $37.629B | 26.04 |
| Koninklijke Philips (PHG) | Netherlands | $28.695B | 18.74 |
| Terumo (TRUMY) | Japan | $21.868B | 24.62 |
| Insulet (PODD) | United States | $19.595B | 60.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.124B | 11.30 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.309B | 0.00 |
| Baxter (BAX) | United States | $10.358B | 8.36 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.713B | 31.33 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.538B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.475B | 13.63 |
| Haemonetics (HAE) | United States | $3.881B | 17.27 |
| Envista Holdings (NVST) | United States | $3.844B | 22.06 |
| ICU Medical (ICUI) | United States | $3.732B | 23.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.140B | 14.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.266B | 14.57 |
| Perrigo (PRGO) | Ireland | $2.056B | 5.15 |
| Neogen (NEOG) | United States | $2.038B | 44.62 |
| LeMaitre Vascular (LMAT) | United States | $1.902B | 38.28 |
| Curaleaf Holdings (CURLF) | Canada | $1.845B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.819B | 79.73 |
| Phibro Animal Health (PAHC) | United States | $1.614B | 16.13 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.496B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.436B | 20.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.366B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.157B | 343.43 |
| Capricor Therapeutics (CAPR) | United States | $1.121B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.044B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| InMode (INMD) | Israel | $0.916B | 10.35 |
| Omeros (OMER) | United States | $0.909B | 0.00 |
| CeriBell (CBLL) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.840B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.558B | 15.12 |
| Cresco Labs (CRLBF) | United States | $0.497B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.489B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.436B | 0.00 |
| Evolus (EOLS) | United States | $0.374B | 0.00 |
| Quanterix (QTRX) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.293B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TerrAscend (TSNDF) | Canada | $0.259B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.213B | 0.00 |
| Accendra Health (ACH) | United States | $0.207B | 2.08 |
| Vireo Growth (VREOF) | United States | $0.204B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.75 |
| Biote (BTMD) | United States | $0.115B | 5.02 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.65 |
| Sharps Technology (STSS) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 34.92 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.47 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |